Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00310765 · ClinicalTrials.gov registry record · Phase 4
Pregabalin for Abdominal Pain From Adhesions
A Phase 4 study, sponsored by Henry Ford Health System.
- Terminated
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT00310765 is a Phase 4 study that was terminated before completion, run by Henry Ford Health System. The registered enrollment target is 18 participants.
The verdict
NCT00310765, a Phase 4 study, was terminated before completion, sponsored by Henry Ford Health System.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if pregabalin demonstrates significant reduction in abdominal pain from adhesions.
Interventions
- DRUG Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks
- DRUG Placebo first followed by open label pregabalin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00310765
The ClinicalTrials.gov registry entry for NCT00310765 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks is the first listed.
NCT00310765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00310765 about?
NCT00310765 is a clinical study titled "Pregabalin for Abdominal Pain From Adhesions". The purpose of this study is to evaluate if pregabalin demonstrates significant reduction in abdominal pain from adhesions.
What is the current status of trial NCT00310765?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2006-03. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00310765?
The interventions under investigation include: Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks (DRUG), Placebo first followed by open label pregabalin (DRUG).
Who is sponsoring clinical trial NCT00310765?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.